Diagnostic and Prognostic Metabolites Identified for Joint Symptoms in the KORA Population

Noha Yousri, Gabi Kastenmüller, Wessam G. Alhaq, Rolf Holle, Stefan Kääb, Robert P. Mohney, Christian Gieger, Annette Peters, Jerzy Adamski, Karsten Suhre, Thurayya Arayssi

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

This study aims at identifying metabolites that significantly associate with self-reported joint symptoms (diagnostic) and metabolites that can predict the change from a symptom-free status to the development of self-reported joint symptoms after a 7 years period (prognostic). More than 300 metabolites were analyzed for 2246 subjects from the longitudinal study of the KORA (Cooperative Health Research in the Region of Augsburg, Germany), specifically the fourth survey S4 and its 7-year follow-up study F4. Two types of self-reported symptoms, chronic joint inflammation and worn out joints, were used for the analyses. Diagnostic analysis identified dysregulated metabolites in cases with symptoms compared with controls. Prognostic analysis identified metabolites that differentiate subjects in S4 who remained symptom-free after 7 years (F4) from those who developed any combination of symptoms. 48 metabolites were identified as nominally significantly (p < 0.05) associated with the self-reported symptoms in the diagnostic analysis, among which steroids show Bonferroni significance. 45 metabolites were identified as nominally significantly associated with developing symptoms after 7 years, among which hippurate showed Bonferroni significance. We show that metabolic profiles of self-reported joint symptoms are in line with metabolites known to associate with various forms of arthritis and suggest that future studies may benefit from that by investigating the possible use of self-reporting/questionnaire along with metabolic markers for the early referral of patients for further diagnostic workup and treatment of arthritis.

Original languageEnglish
Pages (from-to)554-562
Number of pages9
JournalJournal of Proteome Research
Volume15
Issue number2
DOIs
Publication statusPublished - 5 Feb 2016

Fingerprint

Metabolites
Joints
Population
Arthritis
Metabolome
Germany
Longitudinal Studies
Referral and Consultation
Steroids
Inflammation
Health
Research
Surveys and Questionnaires
Therapeutics

Keywords

  • arthritis
  • diagnosis
  • joint inflammation
  • metabolomics
  • prognosis
  • rheumatoid arthritis

ASJC Scopus subject areas

  • Chemistry(all)
  • Biochemistry

Cite this

Diagnostic and Prognostic Metabolites Identified for Joint Symptoms in the KORA Population. / Yousri, Noha; Kastenmüller, Gabi; Alhaq, Wessam G.; Holle, Rolf; Kääb, Stefan; Mohney, Robert P.; Gieger, Christian; Peters, Annette; Adamski, Jerzy; Suhre, Karsten; Arayssi, Thurayya.

In: Journal of Proteome Research, Vol. 15, No. 2, 05.02.2016, p. 554-562.

Research output: Contribution to journalArticle

Yousri, N, Kastenmüller, G, Alhaq, WG, Holle, R, Kääb, S, Mohney, RP, Gieger, C, Peters, A, Adamski, J, Suhre, K & Arayssi, T 2016, 'Diagnostic and Prognostic Metabolites Identified for Joint Symptoms in the KORA Population', Journal of Proteome Research, vol. 15, no. 2, pp. 554-562. https://doi.org/10.1021/acs.jproteome.5b00951
Yousri, Noha ; Kastenmüller, Gabi ; Alhaq, Wessam G. ; Holle, Rolf ; Kääb, Stefan ; Mohney, Robert P. ; Gieger, Christian ; Peters, Annette ; Adamski, Jerzy ; Suhre, Karsten ; Arayssi, Thurayya. / Diagnostic and Prognostic Metabolites Identified for Joint Symptoms in the KORA Population. In: Journal of Proteome Research. 2016 ; Vol. 15, No. 2. pp. 554-562.
@article{5b332be18cbd4dddb07ff6e728b81d03,
title = "Diagnostic and Prognostic Metabolites Identified for Joint Symptoms in the KORA Population",
abstract = "This study aims at identifying metabolites that significantly associate with self-reported joint symptoms (diagnostic) and metabolites that can predict the change from a symptom-free status to the development of self-reported joint symptoms after a 7 years period (prognostic). More than 300 metabolites were analyzed for 2246 subjects from the longitudinal study of the KORA (Cooperative Health Research in the Region of Augsburg, Germany), specifically the fourth survey S4 and its 7-year follow-up study F4. Two types of self-reported symptoms, chronic joint inflammation and worn out joints, were used for the analyses. Diagnostic analysis identified dysregulated metabolites in cases with symptoms compared with controls. Prognostic analysis identified metabolites that differentiate subjects in S4 who remained symptom-free after 7 years (F4) from those who developed any combination of symptoms. 48 metabolites were identified as nominally significantly (p < 0.05) associated with the self-reported symptoms in the diagnostic analysis, among which steroids show Bonferroni significance. 45 metabolites were identified as nominally significantly associated with developing symptoms after 7 years, among which hippurate showed Bonferroni significance. We show that metabolic profiles of self-reported joint symptoms are in line with metabolites known to associate with various forms of arthritis and suggest that future studies may benefit from that by investigating the possible use of self-reporting/questionnaire along with metabolic markers for the early referral of patients for further diagnostic workup and treatment of arthritis.",
keywords = "arthritis, diagnosis, joint inflammation, metabolomics, prognosis, rheumatoid arthritis",
author = "Noha Yousri and Gabi Kastenm{\"u}ller and Alhaq, {Wessam G.} and Rolf Holle and Stefan K{\"a}{\"a}b and Mohney, {Robert P.} and Christian Gieger and Annette Peters and Jerzy Adamski and Karsten Suhre and Thurayya Arayssi",
year = "2016",
month = "2",
day = "5",
doi = "10.1021/acs.jproteome.5b00951",
language = "English",
volume = "15",
pages = "554--562",
journal = "Journal of Proteome Research",
issn = "1535-3893",
publisher = "American Chemical Society",
number = "2",

}

TY - JOUR

T1 - Diagnostic and Prognostic Metabolites Identified for Joint Symptoms in the KORA Population

AU - Yousri, Noha

AU - Kastenmüller, Gabi

AU - Alhaq, Wessam G.

AU - Holle, Rolf

AU - Kääb, Stefan

AU - Mohney, Robert P.

AU - Gieger, Christian

AU - Peters, Annette

AU - Adamski, Jerzy

AU - Suhre, Karsten

AU - Arayssi, Thurayya

PY - 2016/2/5

Y1 - 2016/2/5

N2 - This study aims at identifying metabolites that significantly associate with self-reported joint symptoms (diagnostic) and metabolites that can predict the change from a symptom-free status to the development of self-reported joint symptoms after a 7 years period (prognostic). More than 300 metabolites were analyzed for 2246 subjects from the longitudinal study of the KORA (Cooperative Health Research in the Region of Augsburg, Germany), specifically the fourth survey S4 and its 7-year follow-up study F4. Two types of self-reported symptoms, chronic joint inflammation and worn out joints, were used for the analyses. Diagnostic analysis identified dysregulated metabolites in cases with symptoms compared with controls. Prognostic analysis identified metabolites that differentiate subjects in S4 who remained symptom-free after 7 years (F4) from those who developed any combination of symptoms. 48 metabolites were identified as nominally significantly (p < 0.05) associated with the self-reported symptoms in the diagnostic analysis, among which steroids show Bonferroni significance. 45 metabolites were identified as nominally significantly associated with developing symptoms after 7 years, among which hippurate showed Bonferroni significance. We show that metabolic profiles of self-reported joint symptoms are in line with metabolites known to associate with various forms of arthritis and suggest that future studies may benefit from that by investigating the possible use of self-reporting/questionnaire along with metabolic markers for the early referral of patients for further diagnostic workup and treatment of arthritis.

AB - This study aims at identifying metabolites that significantly associate with self-reported joint symptoms (diagnostic) and metabolites that can predict the change from a symptom-free status to the development of self-reported joint symptoms after a 7 years period (prognostic). More than 300 metabolites were analyzed for 2246 subjects from the longitudinal study of the KORA (Cooperative Health Research in the Region of Augsburg, Germany), specifically the fourth survey S4 and its 7-year follow-up study F4. Two types of self-reported symptoms, chronic joint inflammation and worn out joints, were used for the analyses. Diagnostic analysis identified dysregulated metabolites in cases with symptoms compared with controls. Prognostic analysis identified metabolites that differentiate subjects in S4 who remained symptom-free after 7 years (F4) from those who developed any combination of symptoms. 48 metabolites were identified as nominally significantly (p < 0.05) associated with the self-reported symptoms in the diagnostic analysis, among which steroids show Bonferroni significance. 45 metabolites were identified as nominally significantly associated with developing symptoms after 7 years, among which hippurate showed Bonferroni significance. We show that metabolic profiles of self-reported joint symptoms are in line with metabolites known to associate with various forms of arthritis and suggest that future studies may benefit from that by investigating the possible use of self-reporting/questionnaire along with metabolic markers for the early referral of patients for further diagnostic workup and treatment of arthritis.

KW - arthritis

KW - diagnosis

KW - joint inflammation

KW - metabolomics

KW - prognosis

KW - rheumatoid arthritis

UR - http://www.scopus.com/inward/record.url?scp=84957685276&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84957685276&partnerID=8YFLogxK

U2 - 10.1021/acs.jproteome.5b00951

DO - 10.1021/acs.jproteome.5b00951

M3 - Article

C2 - 26653129

AN - SCOPUS:84957685276

VL - 15

SP - 554

EP - 562

JO - Journal of Proteome Research

JF - Journal of Proteome Research

SN - 1535-3893

IS - 2

ER -